Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene

Current Neurology and Neuroscience Reports

Volumn 6, Issue 1, 2006, Pages 37-46

  Andersen, Peter M ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CREATINE; DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; MESSENGER RNA; TOPIRAMATE;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL GENETICS; CLINICAL TRIAL; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENE MUTATION; GENOMIC INSTABILITY; HEREDITY; HUMAN; LIGHT CHAIN; NERVE FIBER TRANSPORT; NEUROFILAMENT; NONHUMAN; PATHOGENESIS; PREVALENCE; PROTEIN AGGREGATION; REVIEW; RISK FACTOR; SURVIVAL TIME; SYSTEMATIC REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; GENETIC HETEROGENEITY; HUMANS; ISOENZYMES; MUTATION; SUPEROXIDE DISMUTASE;

EID: 31544466502     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-996-0008-9     Document Type: Review

References (55)

1. Jonghe PD, Auer-Grumbach M, Irobi J, et al.: Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? Brain 2002, 125:1320-1325.
2. Forestier NL, Maisonobe T, Piquard A, et al.: Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain 2001, 124:1989-1999.
3. Strong M, Gordon PH: Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum? Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6:8-16.
4. Abrahams S, Goldstein LH, Simmons A, et al.: Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain 2004, 127:1507-1517.
5. Paviour DC, Lees AJ, Josephs KA, et al.: Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain 2004, 127:2441-2451.
6. Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP: Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1996, 60:147-151.
7. Logroscino G, Beghi E, Zoccolella S, et al.: Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry 2005, 76:1094-1098.
8. Chiò A, Benzi G, Dossena M, et al.: Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 2005, 128:472-476.
9. Andersen PM, Nilsson P, Keränen ML, et al.: Phenotypic heterogeneity in MND-patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997, 10:1723-1737.
10. Andersen PM, Sims KB, Xin WW, et al.: Sixteen novel mutations in the gene encoding CuZn-superoxide dismutase in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 2:62-73.
11. Jones CT, Swingler RJ, Simpson SA, Brock DJ: Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995, 32:290-292.
12. Aggarwal A, Nicholson G: Age dependent penetrance of three different superoxide dismutase 1 (SOD1) mutations. Int J Neurosci 2005, 115:1119-1130.
13. McDermott CJ, Roberts D, Tomkins J, et al.: Spastin and paraplegin gene analysis in selected cases of MND. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:96-99.
14. Rosen DR, Siddique T, Patterson D, et al.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
15. Liu J, Concepcion L, Jonsson PA, et al.: Toxicity from copper chaperone and dismutase activity-independent accumulation of familial ALS-causing SOD1 mutants with spinal cord mitochondria. Neuron 2004, 43:5-17.
16. Pasinelli P, Belford ME, Lennon N, et al.: ALS-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 2004, 43:19-30.
17. Jonsson A, Ernhill K, Andersen PM, et al.: Motor neuron disease in ALS patient and transgenic mice carrying Gly127insTGGG mutant Human CuZn-Superoxide Dismutase. Brain 2004, 127:73-88.
18. Restagno G, Gomez A, Lombardo F, et al.: The IVS1 +319 t>a of SOD1 gene is not an ALS causing mutation. Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6:45-49.
19. Fukae J, Kubo SI, Hattori N, et al.: Hoarseness due to bilateral vocal cord paralysis as an initial manifestation of familial ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6:122-124.
20. Boukaftane Y, Khoris J, Moulard B, et al.: Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis. Can J Neurol Sci 1998, 25:192-196.
21. Battistini S, Giannini F, Greco G, et al.: SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study. J Neurol 2005, 252:782-788.
22. Jackson M, Al-Chalabi A, Enayat ZE, et al.: Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol 1997, 42:803-807.
23. Garcia-Redondo A, Bustos F, Juan Y, et al.: Molecular analysis of the superoxide dismutase 1 gene in Spanish patients with sporadic or familial amyotrophic lateral sclerosis. Muscle Nerve 2002, 26:274-278.
24. Gellera C: Genetics of ALS in Italian families. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2(Suppl 1):S43-S46.
25. Robberecht W, Aguirre T, Bosch LV, et al.: D90A heterozygosity in the SOD1 gene is associated with familial and apprently sporadic ALS. Neurology 1996, 47:1336-1339.
26. Rezania K, Yan J, Dellefave L, et al.: A rare Cu/Zn superoxide dismutase mutation causing familial ALS with variable age of onset, incomplete penetrance and a sensory neuropathy. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:162-166.
27. Garré C, Ferrera L, Caponetto C, et al.: An Italian dominant FALS Leu144Phe SOD1 mutation: genotype-phenotype correlation. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:167-170.
28. Andersen PM, Forsgren L, Binzer M, et al.: Autosomal recessive adult-onset ALS associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996, 119:1153-1172.
29. Alexander MD, Traynor BJ, Miller N, et al.: "True" sporadic ALS associated with novel SOD-1 mutation. Ann Neurol 2002, 52:680-683.
30. Weber M, Eisen A, Stewart HG, Andersen PM: Preserved slow conducting corticomotoneuronal projections in ALS patients with autosomal recessive D90A CuZn-SOD mutation. Brain 2000, 123:1505-1515.
31. Cudkowicz ME, McKenna-Yasek D, Sapp PE, et al.: Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997, 41:210-221.
32. Niemann S, Joos H, Meyer T, et al.: Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect. J Neurol Neurosurg Psychiatry 2004, 75:1186-1188.
33. Turner MR, Hammers A, Al-Chalabi A, et al.: Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]-flumazenil PET. Brain 2005, 128:1323-1329.
34. Hayward C, Brock DJ, Minns RA, Swingler RJ: Homozygosity for Asn86Ser mutation in the CuZn-superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis. J Med Genet 1998, 35:174.
35. Kato M, Aoki M, Ohta M, et al.: Marked reduction of the Cu/Zn superoxide dismutase polypeptide in a case of familial ALS with the homozygous mutation. Neurosci Lett 2001, 312:165-168.
36. Agar J, Durham H: Relevance of oxidative injury in the pathogenesis of motor neuron disease. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:232-242.
37. Clement AM, Nguyen MD, Roberts EA, et al.: Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003, 302:113-117.
38. Tikka TM, Vartiainen NE, Goldsteins G, et al.: Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neuron disease. Brain 2002, 125:722-731.
39. Drory VE, Gross D: No effect of creatine on respiratory distress in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2002, 3:43-46.
40. Aggarwal A, Nicholson G: Normal complement of motor units in asymptomatic familial (SOD1 mutation) amyotrophic lateral sclerosis carriers. J Neurol Neurosurg Psychiatry 2001, 71:478-481.
41. Krasnianski A, Deschauer M, Neudecker S, et al.: Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain 2005, 128:1870-1876.
42. Lindberg MJ, Byström R, Bokanäs N, et al.: Systematically perturbed folding patterns of ALS-associated SOD1 mutants. Proc Natl Acad Sci U S A 2005, 102:9754-9759.
43. Rakhit R, Crow JP, Lepock JR, et al.: Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial ALS. J Biol Chem 2004, 279:15499-15504.
44. Vlug AS, Jaarsma D: Long term proteasome inhibition does not preferentially afflict motor neurons in organo-typical spinal cord cultures. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:16-21.
45. Menzies FM, Cookson MR, Taylor RW, et al.: Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 2002, 125:1522-1533.
46. Ge WW, Wen W, Strong W, et al.: Mutant copper-zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. J Biol Chem 2005, 280:118-124.
47. Kieran D, Hafezparast M, Bohnert S, et al.: A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol 2005, 169:561-567.
48. Ligon LA, LaMonte BL, Wallace KE, et al.: Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons. Neuroreport 2005, 16:533-536.
49. Ravikumar B, Acevedo-Arozena A, Imarisio S, et al.: Dynein mutations impair autophagic clerance of aggregate-prone proteins. Nat Genet 2005, 37:771-776.
50. Fischer EM, Ahmad-Annuar A, Shah P, et al.: No association with genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:150-157.
51. Puls I, Oh SJ, Sumner CJ, et al.: Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann Neurol 2005, 57:687-694.
52. Münch C, Sedlmeier R, Meyer T, et al.: Point mutation of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 2004, 63:724-726.
53. Münch C, Rosenbohm A, Sperfeld AD, et al.: Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol 2005, 58:777-780.
54. Shaw CE, Enayat ZE, Chioza BA, et al.: Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol 1998, 43:390-394.
55. Orrell RW, Habgood JJ, Gardiner I, et al.: Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 1997, 48:746-751.